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Cell adhesionnt requires vitamin A (retinol, ROL). The role of vitamin A at speciﬁc times during
eye development was studied in rat fetuses made vitamin A deﬁcient (VAD) after embryonic day (E) 10.5 (late
VAD). The optic ﬁssure does not close in late VAD embryos, and severe folding and collapse of the retina is
observed at E18.5. Pitx2, a gene required for normal optic ﬁssure closure, is dramatically downregulated in
the periocular mesenchyme in late VAD embryos, and dissolution of the basal lamina does not occur at the
optic ﬁssure margin. The addition of ROL to late VAD embryos by E12.5 restores Pitx2 expression, supports
dissolution of the basal lamina, and prevents coloboma, whereas supplementation at E13.5 does not.
Surprisingly, ROL given as late as E13.5 completely prevents folding of the retina despite the presence of an
open fetal ﬁssure, showing that coloboma and retinal folding represent distinct VAD-dependent defects.
Retinal folding due to VAD is preceded by an overall reduction in the percentage of cyclin D1 positive cells in
the developing retina, (initially resulting in retinal thinning), as well as a dramatic reduction in the cell
adhesion-related molecules, N-cadherin and β-catenin. Reduction of retinal cell number combined with a
loss of the normal cell–cell adhesion proteins may contribute to the collapse and folding of the retina that
occurs in late VAD fetuses.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe importance of vitamin A (retinol) in eye development was ﬁrst
demonstrated in the 20th century in animals subjected to varying
degrees of vitamin A deﬁciency. Pregnant pigs or rats with a borderline
deﬁciency in vitamin Awere shown to give rise to fetuses or neonates
with congenital eye abnormalities, including anophthalmia, coloboma,
eversion or folding of the retina and/or retrolenticular ﬁbroplasia
(Hale, 1933, 1935; Warkany and Schraffenberger, 1944, 1946). In these
early studies however, the severity of the vitamin A deﬁciency varied
from animal to animal and fetal survival was low, making it difﬁcult to
study the basis for the defects in any detail. Thus, the mechanism(s)
whereby vitaminA exerts its effects in normal eye development during
the latter part of pregnancy remains largely unexplained.
Embryonic eye development is a multi-step process that involves
tissue induction, as well as the proliferation and differentiation of
cells to form mature tissue. The eye originates from the forebrain
neuroectoderm, ﬁrst forming the optic vesicle, which then invagi-
nates and forms the double-layered optic cup (Harada et al., 2007). Atry, University of Wisconsin-
USA. Fax: +1 608 262 7122.
t-Dame).
l rights reserved.role for vitamin A in optic cup formation has been described (Mic et
al., 2004). The optic ﬁssure, which arises later from the invagination of
the optic vesicle, is a transient structure in the developing eye; it
allows the mesenchyme and hyaloid vasculature to enter into the
optic cup and then closes during normal embryonic development
(Gregory-Evans et al., 2004; Harada et al., 2007). Coloboma, which
means a gap or ﬁssure in the eye, is caused by defective optic ﬁssure
closure (Mann, 1957; Onwochei et al., 2000; Gregory-Evans et al.,
2004). Persistence of the optic ﬁssure results in penetration of the
optic cup by mesenchymal tissue and eversion of the retina in the
cleft region (Mann, 1957). Colobomawas reported at an 18% frequency
in fetuses from rats with a borderline deﬁciency of vitamin A. Retinal
eversionwas reported at a similar frequency (27%; Wilson et al., 1953)
and was believed to be related to typical coloboma (Warkany and
Schraffenberger, 1946).
Retinol is the primary circulating form of the vitamin and is stored
in the liver and other tissues as a retinyl ester; retinol supports all
known functions of vitamin A. The vitamin A metabolite, all-trans
retinoic acid (atRA), is generated though a series of oxidation reactions
starting with retinol followed by the generation of all-trans retinalde-
hyde and ﬁnally atRA, which functions in cellular growth and
differentiation (Clagett-Dame and DeLuca, 2002). atRA acts by binding
to the nuclear retinoic acid receptors (RAR). The RAR heterodimerizes
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transcription of atRA-responsive genes in a ligand-dependent fashion.
The importance of RAR signaling in the developing eye is supported by
the ﬁnding that RARα/γ compound null mutant mice exhibit eye
defects similar to those reported in VAD fetuses (Lohnes et al., 1994).
A nutritional model of late embryonic vitamin A deﬁciency was
recently reported (See et al., 2008). Normal fetal development is
supported in pregnant vitamin A deﬁcient (VAD) rats by feeding an
exogenous source of atRA, and fetal vitamin A deﬁciency is instituted
after embryonic day 10.5 (E10.5) by reducing the level of atRA in the
maternal diet. A rapid state of deﬁciency is induced because atRA has a
short biological half-life and is not stored in tissues. Using this
approach, vitamin A deﬁciency-induced eye defects of similar severity
are produced in all fetuses making it possible to perform molecular
studies aimed at understanding the basis for these developmental
defects. The current report focuses on determining the temporal
requirement for vitamin A in eye development, and examines the
molecular basis whereby the vitamin supports normal closure of the
optic ﬁssure. New roles for vitamin A in the regulation of cell
proliferation, differentiation and cell–cell adhesion in the developing
retina are also reported.
Materials and methods
Generation of rat embryos
Female rats (Harlan Sprague–Dawley, Madison, WI) were depleted
of vitamin A andmated as previously described (White et al., 1998; See
et al., 2008), and assigned to various dietary treatment groups. Food
intakewasmeasured daily from E0.5 to the day of sacriﬁce and did not
differ between the groups. The atRA content of the diets was assessed
as previously described (White et al., 1998) and was ±10% of the
desired value.
Histological analysis
Embryos were collected and ﬁxed overnight in 4% paraformalde-
hyde (E14.5 and E16.5) or in Bouin's ﬂuid (E18.5) (VWR Scientiﬁc
Products, West Chester, PA) for 5–7 days at 4 °C and embedded as
described (See et al., 2008). Sections (10 μm) from E14.5 and E16.5
embryos were stained with Gill's Hematoxylin and Eosin (H&E) while
sections from E18.5 fetuses were stained with Groat's Hematoxylin
andMallory's Trichrome stain. Eight to thirteen embryos from three to
seven independent litters were analyzed at E14.5 and E16.5; nine to
twelve fetuses from three to ﬁve independent litters were analyzed at
E18.5.
Generation of riboprobes, vibratome sectioning and in situ hybridization
Rat embryos (E14.5) were collected and ﬁxed in 4% paraformalde-
hyde, dehydrated into 100% methanol and stored at −20 °C until use.
Embryos were rehydrated to phosphate buffered saline (PBS),
embedded in 3% agarose in PBS at 65 °C and stored at 4 °C overnight.
Embryos were then sectioned frontally at 200 μm using a vibratome
(Leica, Wetzlar, Germany).
The Pitx2 riboprobe (536 bp) was prepared using methods
described previously (Kaiser et al., 2003) using the following primer
pair: 5′-ACTCTGCCCGAGAAAGACTGAGAA-3′ and 5′-TCAGAAACAAGG-
CATCCACCAGAG-3′. In situ hybridization of ﬂoating sections was
carried out as described previously (Kaiser et al., 2003). The sense
probe was evaluated as a negative control and no signal was detected
(data not shown). Five to six embryos from at least three independent
litters were analyzed per group. Imaging of slides and sections was
done using a Spot camera (Spotcam, Diagnostic Instruments Inc.,
Sterling Heights, MI) and MetaMorph software (Molecular Devices,
Downingtown, PA).Immunoﬂuorescence studies
Dent's ﬁxed (methanol:dimethyl sulfoxide 4:1) embryos were
dehydrated to 100% ethanol and embedded in parafﬁn for microtome
sectioning at 10 μm.Sectionswere deparafﬁnized and rehydrated in PBS,
blocked in 5% normal goat serum (NGS) in PBS containing 0.05% Tween
20 for 30 min, and then incubated in primary antibodies diluted in 5%
NGS in PBS at 4 °C overnight. Sections were washed in PBS with 0.05%
Tween-20 followedby incubationwithAlexa Fluor secondaryantibodies
(1:100–1000 in PBS, Molecular probes) at room temperature for 1 h.
Sections were then incubated with nuclear stain 4′6-diamindino-2-
phenylindole (DAPI) (1:1000 in PBS, Invitrogen). The primary antibodies
used were mouse anti-βIII-tubulin (clone 5G8, 1:1000, Sigma), mouse
anti-islet-1 (clone 40.2D6 supernatant; Developmental Studies Hybri-
doma Bank); rabbit anti-laminin (directed to both the 220 and 440 kDa
chains, 1:100, Serotec), mouse anti-cyclin D1 (clone 72-13G, 1:50, Santa
Cruz), mouse anti-N-cadherin (clone 32/N, 1:200, BD Biosciences) and
rabbit anti-β-catenin (to a peptide region including serine 37,1:200, Cell
Signaling). A minimum of 6 embryos from at least 3 independent litters
were analyzed per group for each antibody.
Imaging of sections was done by Metamorph or QED Capture
software. Cyclin D1 quantitation was done by imaging embryonic
sections at 40×magniﬁcation in themedial/dorsal region of the retina.
Cyclin D1 positive cells and DAPI positive cells in an area of
215×173 μm were counted and the number of positive cells was
expressed as percentage of the total number of cells. Three retinal
sectionswere counted fromeach embryo and a total of 6 embryos from
3 independent litters/group at each stage were studied. Statistical
analysis was done using a one-way analysis of variance (ANOVA)
followed by pairwise comparisons (Tukey HSD, Sheffe test and Fisher's
least signiﬁcant difference test; signiﬁcance set at pb0.05).
Results
The optic ﬁssure fails to close in late VAD embryos
Closure of theopticﬁssure in the rat embryo begins at E13 (late E11 in
mouse) and the process is complete by E15 (E13 in mouse, Hero, 1990).
When examined at E14.5, optic ﬁssure closure was nearly complete
(except in the optic disk region) in all vitamin A-sufﬁcient (VAS) control
embryos (group I; n=8 from 3 independent litters; Supplementary Fig.
1A), and by E16.5, the optic ﬁssure was completely closed in 100% of the
VAS embryos (Fig. 1A). In contrast, when a state of late embryonic
vitamin A deﬁciency was imposed (group II), the ﬁssure was open in
100% of embryos at E14.5 (8 embryos from 4 independent litters;
Supplementary Fig. 1B, arrowhead). The failure of the optic ﬁssure to
closewas not the result of a developmental delay, as it remained open in
all late VAD embryos at E16.5 (Fig.1B, white arrowhead). In themajority
of late VAD embryos (5/7), the ﬁssure was open throughout the entire
retina, and extended through the optic disc/nerve. Thus, failure of optic
ﬁssure closure is fully penetrant in late VAD embryos.
In order to investigate the temporal requirement for vitamin A, ROL
was administered to pregnant rats starting at later times (E11.5 to E15.5),
followed by analysis of eye development at E16.5 (Fig. 1). Delaying the
addition of ROL by one day (starting at E11.5) supported optic ﬁssure
closure in all embryos (Fig. 1C), whereas the addition of ROL at E12.5
supported closure in most (83%, Fig. 1D), and yielded coloboma in only
17% (Fig. 1E, white arrowhead). However, when ROL supplementation
was startedonor after E13.5 (groupsV, VI andVII), the opticﬁssure failed
to close in 100% of embryos (Figs. 1F–H, white arrowheads).
The basement membrane fails to dissolve at the optic ﬁssure in late VAD
embryos
Closure of the optic ﬁssure begins as the ﬁssure margins approach
each other followed by inversion of the outer layer of the optic cup.
Fig. 1. The relationship of time of ROL supplementation in late VAD embryos to optic
ﬁssure closure. Maternal dietary treatment groups and analysis of optic ﬁssure closure
at E16.5. Top panel: VAD female rats were fed puriﬁed diets containing atRA in the
amounts shown, and somewere given an oral daily dose of 500 IU of retinol (ROL) in the
form of retinyl palmitate starting at E10.5, 11.5, 12.5, 13.5, 14.5 or 15.5. Bottom panel (A–
H): Sections of the ventral retina region from representative embryos from each
treatment group at E16.5 stained with H&E. The value in the lower right indicates the
percentage of embryos showing that phenotype (either a closed or open optic ﬁssure).
The cartoon shows the relative orientation of the sections (transverse through the eye).
All embryos receiving supplemental ROL at E10.5 (VAS) show complete closure of the
optic ﬁssure (A, n=7 from 5 independent litters) whereas the ﬁssure (white arrowhead)
is open in all the late VAD group II embryos (B, n=7 from 5 independent litters). The
optic ﬁssure is closed in all embryos given ROL starting on E11.5 (C, n=6 from 4
independent litters), whereas delaying supplementation by one day is slightly less
effective, with 83% closed (D, n=10/12 from 4 independent litters); 17% (n=2/12) show
an open optic ﬁssure (E). Supplementation of ROL starting on E13.5 (F), E14.5 (G) or
E15.5 (H) does not support optic ﬁssure closure and results in 100% coloboma in
embryos (n=6, 6 and 5 from 4, 4 and 3 independent litters, respectively). atRA, all-trans
retinoic acid; IU, international units, l, lens; r, retina; black arrow, eversion of the retina
at the ﬁssure.
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disintegrates and the ﬁssure closes (Hero, 1989). Because laminin is a
major component of the basal lamina in the basement membrane
(Gumbiner, 1996; Torres et al., 1996), this matrix protein was studied.
At E13.5, contact-dependent dissolution of the basal lamina had
occurred normally in all VAS group I embryos (Fig. 2A, arrow), and by
E14.5, there was no longer any evidence of the ﬁssure, either by anti-
laminin or DAPI staining (Figs. 2C and E). In contrast, despite the fact
that the ﬁssure margins were closely apposed at E13.5 in all late VAD
embryos, dissolution of the basal lamina did not occur as evidenced by
the persistence of laminin staining (Fig. 2B, arrowhead). Laminin
staining was evident at the margin of the ﬁssure at two later
developmental times (E14.5 and E16.5; Figs. 2D and H, arrowheads). In
order to deﬁne exactly when vitamin A is needed to support
dissolution of the basal lamina, laminin staining at the ﬁssure margin
was studied at E16.5 in embryos given ROL at varying times on or after
E10.5 for the groups shown in Fig. 1. Dissolution of the basal lamina
occurred in those given supplemental ROL at E10.5 and 11.5 (Figs. 2G
and I), and in the majority of embryos supplemented at E12.5 (67%;
Fig. 2J). However, if ROL was delayed to E13.5 or thereafter, laminin
staining persisted at the neuroepithelial lips in 100% of embryos (Figs.
2L–N, arrowheads). These results illustrate that E11.5–E13.5 is a
critical period when vitamin A is required to support both disintegra-
tion of the laminin-containing basement membrane and optic ﬁssure
closure.
It has been proposed that incomplete closure of the optic ﬁssure
could result from precocious differentiation of cells at the margin of
the ﬁssure (Lohnes et al., 1994). In order to determine whether the
onset of neuronal differentiation might be occurring earlier due to
VAD, the expression of βIII-tubulin the earliest marker for cells that
have exited the cell cycle and are undergoing differentiation (Philips et
al., 2005) was studied. There was no evidence of βIII-tubulin staining
of cells at the ﬁssure margin, either at E13.5 or 14.5 in the late VAD
group, indicating that precocious differentiation was not occurring
(data not shown).
Analysis of coloboma-related genes
In order to better understand the molecular basis for the lack of
optic ﬁssure closure, a number of transcription factors known to be
essential for this process were studied. Coloboma has been reported in
mouse embryos null for Vax1, Vax2, Pax2, Pax6 and Pitx2 (Barbieri et
al., 2002; Baulmann et al., 2002; Bertuzzi et al., 1999; Hallonet et al.,
1999; Gage et al., 1999; Torres et al., 1996). Vax1, Vax2, and Pax2 are
normally conﬁned to the ventral retina, whereas Pax6 is more
generally distributed, and Pitx2 is found in the periocular mesench-
yme (POM). Tbx5 was also studied as a dorsal retina marker. In situ
hybridization and immunoﬂuorescence studies of the retina showed
that neither the dorsal/ventral location nor the absolute levels of Vax1,
Vax2, and Tbx5mRNAs or Pax2 protein were altered at either E12.5 or
13.5, and Pax6 protein was not changed at E14.5 in the late VAD
embryos when compared to the VAS group (Supplementary Fig. 2 and
data not shown). Thus, dorsoventral patterning of the retina appeared
normal in embryos receiving no supplemental ROL between E10.5
(∼12–15 somite stage) and E13.5.
In contrast, the expression of Pitx2 was dramatically reduced in all
late VAD embryos. Pitx2 is a homeobox gene that is required both for
optic ﬁssure closure and anterior eye development (Gage et al., 1999).
At E14.5 Pitx2 mRNA was expressed both in the periocular
mesenchyme (POM) and ocular muscles of all VAS embryos (Fig.
3A), whereas, it was nearly undetectable in most regions of the POM
except in the most anterior region of the mesenchyme in the late
VAD group II (Fig. 3B). Addition of supplemental ROL at E12.5 rescued
the normal pattern of Pitx2 mRNA expression in the majority of
embryos examined (Fig. 3C), whereas the remainder showed lesser
expression (Fig. 3D). Pitx2 expression was even more severely
Fig. 3. Pitx2mRNA is downregulated at E14.5 in the periocular mesenchyme (POM) due
to vitamin A deﬁciency. Pitx2 is highly expressed in the periocular mesenchyme (POM)
of all VAS embryos (A, n=6) and is downregulated both by late VAD (B, n=6) and in the
group not receiving supplemental ROL until E13.5 (E, n=6). The Pitx2 expression level
varied in the POM of group IV embryos with 3/5 appearing as in (C), and 2/5 as in (D). l,
lens; r, retina.
Fig. 2. ROL is required between E11.5 and 12.5 for dissolution of the basal lamina. Top
panel (A–F): Laminin staining persists at the optic ﬁssure margin in late VAD embryos.
Immunoﬂuorescence of the basal lamina marker, laminin (green; A–D), at E13.5 and
E14.5, and staining of the cell nuclei with DAPI at E14.5 (white; E, F), in transverse
sections through the eye. Laminin staining is largely absent from the ﬁssure margin
(arrow) at E13.5 in the VAS embryo (A), and by E14.5, the ﬁssure margin is no longer
evident by either anti-laminin (C) or DAPI (E) staining. Note the persistence of laminin
staining at the ﬁssure margin in the late VAD embryos at both stages (B, D, and F; white
arrowheads). Bottom panel (G–N): Laminin immunoﬂuorescence at E16.5. The optic
ﬁssure is closed in all VAS embryos (G) and in those supplemented with ROL at E11.5 (I).
Supplementationwith ROL from E12.5 (group IV) results in partial rescue; four out of six
of the embryos show dissolution of laminin at the ﬁssure margins (J) whereas 2 of 6
show persistence of laminin at the ﬁssure margin (K, arrowhead). Laminin staining
persists at the ﬁssure margin in 100% of the embryos when ROL is supplemented on or
after E13.5 (L–N), and in the late VAD group (H). Five to six embryos/group were
analyzed from 3 to 5 independent litters. l, lens; r, retina.
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supplemental ROL until E13.5 (Fig. 3E). Thus, if ROL was added at
E12.5, Pitx2 expression was largely rescued and coloboma was
prevented in most embryos, whereas the addition of ROL at E13.5
did not normalize Pitx2 in the POM and coloboma was observed.
Therefore, the time when vitamin A is needed to support normal
Pitx2 expression in the POM, coincides exactly with the time when
it is also needed to support closure of the optic ﬁssure, suggesting
that the loss of Pitx2 expression may participate in the development
of coloboma in late VAD fetuses.The temporal requirement for ROL differs for several aspects of eye
development
In addition to coloboma, a number of additional defects have been
reported as a part of the vitamin A deﬁciency syndrome (Warkany and
Schraffenberger, 1944, 1946; See et al., 2008) including absence of the
anterior chamber, loss of or rudimentary iris, corneal-lenticular stalk/
fusion, small conjunctival sac, folding of the retina, absence of the
vitreous body and the presence of a ﬁbrous retrolenticular membrane.
All of these defects were seen in the present study at E18.5 in the late
VAD group (Fig. 4B and Table 1), whereas eye development appeared
normal in the control group I (Fig. 4A). In addition, thickening of the
eyelid folds was noted in late VAD embryos (Table 1). When the
temporal requirement of vitamin A to support each of these aspects of
eye development was examined, ROL supplementation starting on
E11.5 supported normal eye development (Fig. 4C), whereas delaying
ROL supplementation to E12.5 (group IV) yielded anterior eye defects
including the absence of the anterior chamber, loss of or rudimentary
iris and corneal lenticular stalk/fusion in 40–50% of the fetuses (Figs.
4D and E; Table 1). Interestingly, retinal thinning, which has not
previously been described as a part of the fetal vitamin A deﬁciency
syndrome, was observed in 40% of the fetuses (Fig. 4E). Retinal
thinning and a thickened eyelid in addition to the aforementioned
anterior eye defects were observed in the majority of fetuses when
ROL was delayed to E13.5 (Fig. 4F; Table 1). Further delay of ROL
addition to E14.5 resulted in fetuses with even more severe
abnormalities including retinal folding in the majority (Fig. 4H),
absence of the vitreous body (50%), and the appearance of a ﬁbrous
retrolenticular membrane (75%). These defects became 90% penetrant
or greater when ROL supplementation was delayed to E15.5 (Figs. 4I
and J; Table 1). Thus, vitamin A is needed by E11.5 to support
development of anterior eye structures, but can be given as late as
E13.5 to support development of the vitreous body and to prevent
appearance of a ﬁbrous retrolenticular membrane, and severe folding
of the retina.
It has been previously suggested that eversion of the retina and the
penetration of the optic cup by mesenchymal tissue are caused by the
persistence of the optic ﬁssure (Lohnes et al., 1994). Although some
retinal eversionwas noted at the ﬁssuremargins at E16.5 in the groups
exhibiting coloboma (Figs. 1B, G and H, black arrows), the results from
the present study argue that vitamin A deﬁciency-dependent
coloboma and the severe retinal folding seen in late VAD fetuses
Fig. 4. ROL is needed at different times to prevent the appearance of speciﬁc late vitamin A deﬁciency-induced eye defects. Groat's Hematoxylin and Mallory's Trichrome stained
transverse sections of E18.5 fetuses (A–J). Normal eye development is observed in VAS fetuses (A) and severe eye defects, including retinal folding, are observed in late VAD fetuses
(B). Normal eye development is observed in all fetuses when ROL is added at E11.5 (C) and in 60% when added by E12.5 (D). Retinal thinning and other anterior eye defects are
observed in the other 40% of group IV fetuses (E) and 85% of those in group V receiving ROL by E13.5 (F). Retinal folding is apparent in themajority of fetuses when ROL is added at 14.5
(H) and 15.5 (J). Note, the small percentage of fetuses in group VI (G) and VII (I) that do not display retinal folding show severe retinal thinning. The numbers in A, C and D indicate the
percentage of fetuses that appear morphologically normal; in E, F, G and I the percentage with retinal thinning; and B, H and J, those with retinal folding. a, anterior chamber; c,
cornea; i, iris; j, conjunctiva; on, optic nerve; r, retina; v, vitreous body.
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present in 100% of embryoswhen the ROL supplement was given on or
after E13.5, whereas no retinal folding was observed in any fetus that
received ROL at E13.5 (Fig. 5). However, delaying the addition of ROL
by one day (to E14.5) produced retinal folding in the majority of
fetuses. Thus, coloboma was completely prevented by addition of ROL
on or before E11.5 whereas retinal folding could be prevented by
administration of ROL at a later time (E13.5), arguing that coloboma
per se is not the cause of the retinal folding in the late VAD fetuses.Table 1
Eye abnormalies1
1Tissues were scored as normal (open box), mildly abnormal (grey box), or severely abno
that phenotype. The percentage of fetuses showing any abnormality (mild or severe) is s
2Retinal coloboma was assessed at E16.5; other defects were assessed at E18.5.
3Retinal thinning could not be scored in groups that received ROL from E14.5 (group VI), E
collapse that was present in the majority of embryos. Note the two fetuses that showed no
thinning. N/A, not applicable.Retinal folding in late VAD fetuses
In order to better understand how vitamin A deﬁciency might lead
to retinal folding, the morphology of the retina was examined more
closely at E16.5 in VAS and late VAD fetuses, as well as in those
supplemented with ROL starting at different times ranging from E11.5
to E15.5. The retinas of VAS group I embryos appeared normal with
oval-shaped nuclei oriented radially along the apical–basal axis of the
retina (Fig. 6A, top panel, H&E staining). In contrast, the cell bodies ofrmal (black box). The numbers in the box indicate the number of embryos showing
hown underneath the box.
15.5 (group VII) and in the late VAD group, due to the severity of the retinal folding/
retinal folding (one fetus in group VI and one from group VII) showed severe retinal
Fig. 5. Relationship of the timing of ROL addition to the appearance of coloboma (circle,
dotted line) and retinal folding (square, solid line). Note when ROL is supplemented on
E13.5, 100% of fetuses display coloboma yet none show retinal folding (grey dotted line).
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rounded up (Fig. 6B, top panel, black arrowhead), and many cells had
lost their normal orientation. Even more dramatic were areas in the
DAPI-stained retinal section that appeared to be devoid of cellular
material (Fig. 6B, bottom panel, white arrowhead). Delaying ROLFig. 6. The effect of ROL supplementation on retinal morphology at E16.5. The dorsal region o
groups I to VII. Oval shaped-retinal cell bodies and processes are oriented radially along the ap
is less well organized when ROL is delayed to E13.5 (E), and rounded cells lacking processes
between cells are apparent in groups receiving ROL on or after E14.5 (F, G), and in late VADsupplementation to E11.5 or 12.5 (groups III and IV) did not alter
retinal morphology from that seen in the VAS group I (compare Figs.
6C and D to A). However, when ROL addition was delayed to E13.5
(group V), the retina cell bodies began to look somewhat abnormal
(compare Figs. 6E to A, C and D), and when supplementation was
delayed to E14.5 or 15.5, large areas devoid of cellular material became
evident (Figs. 6F and G). The location where the “holes” appeared in
the VAD retinas appeared to correspond to the border between the
proliferating retinal progenitor cells (RPC; brighter DAPI staining) and
the differentiating neuronal cell layer (lighter DAPI staining). Thus, it is
possible that a loss of structural integrity and collapse of the retina
could have resulted from a reduction in the number of retinal cells or a
change in the adhesive properties of the proliferating and/or
differentiating cell populations.
Cellular proliferation and the time-course of ventral retina
differentiation, but not cell death, is altered in the retina of late VAD
embryos
During retinogenesis, RPCs oscillate between the apical and basal
surface of the retina and undergo cell division, and those that exit the
cell cycle undergo neuronal differentiation (Donovan and Dyer, 2005).
At approximately E13.5 of development in the rat, differentiationf the retina stained with H&E (top half panel) and DAPI (bottom half panel) is shown for
ical–basal axis of the retinawhen ROL is provided on or before E12.5 (A, C, D). The retina
(black arrowhead, H&E panel) as well as empty spaces (white arrowhead, DAPI panel)
embryos (B).
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differentiation initiates ﬁrst near the inner part of the central optic cup
and progresses concentrically in a wave-like manner until reaching
the peripheral retina (Marquardt and Gruss, 2002). Retinal ganglion
cells (RGC) are the ﬁrst differentiated cell type to appear. They exit the
cell cycle and begin expressing βIII-tubulin, and migrate to the basal
surface (marginal layer) of the developing retina. This leads to the
development of a retina containing both an outer proliferating (apical)
and inner differentiating (basal) layer.
In order to understand why the retina appeared less compact and
to explore the basis for the presence of the cell-free regions, cellular
proliferation and cell death were analyzed in frontal retinal sections
from VAS control and late VAD embryos at E13.5, 14.5 and 15.5. Cell
proliferation was analyzed using antibodies to cyclin D1, as well as
Ki67 and phosphohistone 3 (H3P). Cyclin D1 is important for
proliferation as it regulates the exit of G1 phase/entrance of S phase
(Donovan and Dyer, 2005; Sanchez and Dynlacht, 2005; Sherr, 1995),
Ki67 is present during all active phases of the cell cycle (Scholzen and
Gerdes, 2000) and H3Pmarks cells undergoing mitosis (Hendzel et al.,
1997). The number of cyclin D1 positive cells expressed as a
percentage of DAPI-stained nuclei is shown in Fig. 7A. Cyclin D1-
expressing cells were located throughout the retina in VAS group I
embryos at E13.5 and in the proliferating layer at E14.5 and E15.5, and
the percent of cyclin D1 positive cells was signiﬁcantly reduced in late
VAD embryos (group II) at all times studied (p-valueb0.05). The
percent of Ki67 positive cells in the retina was also signiﬁcantly
reduced in the late VAD group (p-valueb0.01), and the number of cellsFig. 7. The percentage of cyclin D1 positive cells is reduced by vitamin A deﬁciency. The
percent of cells positive for cyclin D1 is signiﬁcantly reduced in the late VAD group
when evaluated at E13.5, E14.5 and E15.5 (A). At E14.5, the percent of cyclin D1 positive
cells in groups IV (ROL from E12.5), V (ROL from E13.5) or in the late VAD group (Group
II) is signiﬁcantly lower than the VAS group (B). Values are mean+standard deviation.
⁎p-valueb0.05 compared to the VAS group.undergoing mitosis was modestly reduced (although it was not
statistically signiﬁcant) from E13.5 to E16.5 (Supplementary Fig. 3).
Analysis of cyclin D1 in embryos in which ROL supplementation was
delayed to E12.5 showed there was a small but signiﬁcant decrease of
the percent of cells stained, and a more dramatic reduction was noted
when ROL was delayed to E13.5 or was not added at all (late VAD
group II) (Fig. 7B).
Cell death in the developing retina was analyzed using both the
TUNEL assay and by immunoﬂuorescence using an antibody to
cleaved caspase-3. No difference in number of apoptotic cells was
observed by TUNEL assay at E13.5, E14.5, E15.5 and E16.5 in late VAD
retinas when compared with VAS controls, whereas positive staining
was readily observed in the periocular mesenchyme, a region known
to undergo apoptosis at these times (data not shown). Additionally,
there was no difference in cleaved caspase-3 immunoreactivity
between VAD and VAS retinas at E13.5, E14.5 and E15.5 (Supplemen-
tary Fig. 4 and data not shown). Collectively, these results support the
conclusion that late VAD caused a reduction in retinal cell prolifera-
tion rather than an increase in cell death. It is also notable that when
ROL supplementation was delayed to E12.5, there was both a
reduction in the percentage of cyclin D1 positive cells and retinal
thinning, showing that the timewhen vitamin A is required to support
normal cell proliferation coincides with the time when it is needed to
maintain the normal dimension of the expanding retina.
Neuronal differentiation is delayed in the ventral retina of late VAD
embryos
If the processes of cell proliferation and differentiation are
uncoupled, abnormalities in retinal development may result (Dyer
and Cepko, 2001). In order to determine whether the onset of
neuronal differentiation was affected in late VAD embryos, the
expression of βIII-tubulin was examined along the dorsoventral axis
of the developing retina at E14.5 and E15.5. In the VAS control group at
E14.5, βIII-tubulin-positive cells were beginning to appear in the inner
layer of the central part of the retina both dorsal and ventral to the
position where the optic nerve will form (Fig. 8A). Although βIII-
tubulin expression was seen in the dorsal retina in late VAD embryos,
staining was absent at E14.5 in the ventral region (Fig. 8B). Islet-1 also
marks differentiating RGCs, and at E14.5 staining was observed in a
pattern similar to that of the βIII-tubulin in VAS control retinas
(compare Figs. 8C to A). In contrast, islet-1 staining was present in the
dorsal, but not the ventral differentiating layer of the retina in the late
VAD group at this time (Fig. 8D). Staining for additional RGC cell
markers (Brn3b and doublecortin; Rachel et al., 2002) conﬁrmed the
presence of RGCs in the dorsal but not the ventral region of the retina
at E14.5 in the late VAD group (Supplementary Fig. 5).
Interestingly, by E15.5, staining for both islet-1 and βIII-tubulin
could be seen both in the dorsal and ventral retina of both VAS and
late VAD embryos (compare Figs. 8E to F and data not shown).
However, closer examination of the βIII-tubulin-positive cells in the
late VAD retinas at E15.5 showed that the differentiating RGCs now
present along both the dorsal and ventral axes, appeared abnormal
(Fig. 8H, arrowheads). Rather than being elongated in cell shapewith a
radial arrangement along the apical–basal axis (Fig. 8G), the
differentiating RGCs in the late VAD retina appeared rounded in
shape, lost their normal orientation, and most cells lacked the
processes (Fig. 8H) seen in the VAS sections.
Expression of cell adhesion-related proteins is downregulated in late
vitamin A deﬁciency
β-catenin and N-cadherin-mediated cell–cell adhesion is critical
for maintaining the integrity and cellular organization of the retina
(Matsunaga et al., 1988, Fu et al., 2006). Because the cells in the late
VAD retinas were not tightly juxtaposed to one another and the
Fig. 8. Differentiation of the retinal ganglion cells in the ventral retina of late VAD
embryos is delayed. βIII-tubulin (green) and islet-1 (red) antibody staining of RGCs in
the developing retina at E14.5 in VAS (A, C) and late VAD (B, D) embryos. Note, staining
for both RGC markers is absent in the ventral retina of late VAD embryos (B, D). βIII-
tubulin positive cells are observed in the ventral retina at E15.5 in the late VAD embryo
(F); however, aberrantly shaped cells (white arrowheads) and loss of cell processes are
evident in the late VAD group (H). A–F: Scale bar is 100 μm; G–H: scale bar is 50 μm. r,
retina. The results shown are representative of samples from 6 embryos from 6
independent litters for each antibody at each stage.
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protein levels were assessed by immunoﬂuorescence (Fig. 9). At E13.5,
β-catenin was expressed at a low level in the retina of the VAS group
(Fig. 9A). By E14.5 and E15.5, β-catenin was present throughout the
retina, and expressionwas highest at the apical and basal sides where
the processes of the oval-shaped RPCs are anchored (Figs. 9B and C). At
E13.5, β-catenin expression in late VAD embryos was indistinguish-
able when compared to group I (compare Figs. 9D to A). However, at
E14.5 and E15.5, the normal increase in β-catenin levels seen in the
control group did not take place in the late VAD group II embryos
(compare Figs. 9B to E, and C to F).
Similarly, at E13.5, the expression level of N-cadherin was
indistinguishable in groups I and II (compare Figs. 9G to J). By E14.5
and E15.5, the level of N-cadherin expression in VAS retinas had
increased (Figs. 9H and I), with higher expression in the differentiating
cell layer. Like β-catenin, the level of N-cadherin did not show the
normal increase at E14.5 and 15.5 in the late VAD group (compare Figs.
9K and L to H and I). The lack of N-cadherin and β-catenin proteinexpression in the late VAD group was not due to a global effect on cell
protein expression, as the level of F-actin as assessed by phalloidin
staining at E15.5 did not differ between VAS and VAD retinas (data not
shown). The expression of β-catenin and N-cadherin protein was
normal at E16.5 in groups that received ROL supplementation starting
on E10.5 (Figs. 9M and S) and E12.5 (Figs. 9O and U). A moderate
decrease in protein expressionwas observed when ROL supplementa-
tion was started on E13.5 (Figs. 9P and V) and a more dramatic
reduction was noted when ROL was delayed to E14.5 and E15.5 (Figs.
9Q, R, W and X) or was not added at all (Figs. 9N and T). Thus, vitamin
A is required for the increase in β-catenin and N-cadherin proteins
that occurs in the developing retina by E14.5 and thereafter.
Discussion
Vitamin A is required after E11.5 of development to support distinct
events in eye development
The present work shows that severe eye defects develop in
embryos made VAD from E10.5 onward; and further, that different
aspects of development are rescued dependant upon the time when
ROL is added back. All late VAD fetuses have coloboma, absence of the
anterior chamber of the eye, rudimentary or loss of the iris, fusion of
the lens and cornea, and thickening of the eyelid tissues, reduced size
of the conjunctival sac, folding of the retina, absence of the vitreous
body and the presence of a ﬁbrous retrolenticular membrane. A
number of these defects are similar to those described as a part of the
vitamin A deﬁciency syndrome (Warkany and Schraffenberger, 1944,
1946; Wilson et al., 1953). Importantly, a new late vitamin A
deﬁciency-induced defect, retinal thinning, is also revealed in the
present study (Fig. 4).
The present work shows that addition of ROL by E14.5 or 15.5 is
largely ineffective in rescuing any of the eye defects above. Addition by
E13.5 completely prevents the appearance of retrolenticular ﬁbropla-
sia as well as retinal folding, by E12.5 rescues the majority of the
coloboma and defects in anterior eye structures, and by E11.5 rescues
all late vitamin A deﬁciency-induced eye malformations. The time
when eye defects can be completely rescued by the addition of
exogenous vitamin A agrees the work of Wilson et al. (1953), who
showed that postlental membrane, eversion of the retina and
coloboma were prevented with supplemental vitamin A at a similar
time.However, the overall percentage of ocular abnormalities reported
by this groupwas only 49%, 27% and 18%, respectively, for each of these
defects; whereas the penetrance is 100% in the present late VADmodel
system, and unlike earlier studies, the majority of fetuses survive.
The eye defects described in the present report are, in many cases,
more severe than those that have been reported by compound
inactivation of the Raldh or RAR types (Matt et al., 2005; Molotkov et
al., 2006; Halilagic et al., 2007; Lohnes et al., 1994; Ghyselinck et al.,
1997). This may be due to the inability to eliminate by genetic means
all sources of atRA or vitamin A-signaling in the eye, resulting either
from the systemic contribution of atRA by remaining synthetic
enzymes (Li et al., 2000; Wagner et al., 2000; Mic et al., 2002;
Niederreither et al., 2002a,b; Chambers et al., 2007) or by the presence
of RAR isoforms and/or subtypes that can compensate. Like mice null
for Raldh3, we observe a loss of the vitreous body, and the presence of
a retrolenticular membrane between the lens and retina, and similar
to Raldh1−/−/Raldh3−/− double mutants (Matt et al., 2005; Molotkov et
al., 2006), late VAD rat embryos show abnormal thickening of the
eyelid folds. However unlike Raldh1−/−/Raldh3−/− double mutants that
exhibit retinal thickening, rat embryos deﬁcient in vitamin A between
E11.5 and 14.5 show retinal thinning. Interestingly, thickening of the
retina was noted in late VAD embryos rescued with a pharmacological
amount of atRA from E10.5 onward (See et al., 2008), suggesting that
thickening occurs in partial deﬁciency whereas thinning occurs with
more severe vitamin restriction.
Fig. 9. The increase in cell adhesion proteins (N-cadherin and β-catenin) that normally occurs during development of the retina does not take place in late VAD. Top panel (A–L): β-
catenin (cyan) and N-cadherin (yellow) immunoﬂuorescence from E13.5 to E15.5 is shown. β-catenin and N-cadherin expression levels are approximately the same in VAS and late
VAD embryos at E13.5 (compare A with D, and G to J; respectively). β-catenin and N-cadherin protein levels normally increase by E14.5 and E15.5 in VAS embryos, whereas these
proteins are nearly undetectable the late VAD group at E14.5 (compare B to E and H to K; respectively) and E15.5 (compare C to F and I to L; respectively). Bottom panel: The effect of
ROL supplementation on β-catenin and N-cadherin levels in the retina at E16.5. β-catenin and N-cadherin are expressed throughout the retina in VAS embryos (M and S, respectively)
and those receiving supplemental ROL on or before E12.5 (O and U, respectively). The level of both proteins is reduced when ROL is delayed to E13.5 (P and V, respectively). β-catenin
and N-cadherin are nearly undetectable in the retina embryos supplemented with ROL on or after E14.5 (Q, R and W, X, respectively) and the late VAD group (N and T, respectively).
The results shown are representative of samples from 6 embryos from at least 3 independent litters for each marker.
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embryos do not involve molecular abnormalities in dorsoventral
patterning genes, as normal expression of Tbx5 in the dorsal retina,
and Vax1, Vax2 and Pax2 expression in the ventral retina are observed
at both E12.5 and 13.5. Genetic models also show that RA is not
required for early dorsoventral patterning of the retina. Tbx5, Vax2
and Pax2 expression is normal in Raldh1−/−/Raldh3−/− embryos (Matt et
al., 2005), and triple mutants (Raldh1, 2 and 3) still express Vax2
(Molotkov et al., 2006). Likewise, Raldh2−/+/Raldh3−/− mutants do not
show strong defects in the molecular determinants involved in eye
patterning at E9.5 of development, yet go on to develop a disorganized
retina, and retrolenticular membrane. Our work clearly shows that the
molecular abnormalities that account for the severe morphological
eye defects, must occur after E11.5 (coloboma, absence of the anterior
chamber, loss of or small iris, corneal lenticular stalk, reduction in
conjunctival sac and retinal thinning) or E13.5 (folding of the retina,
absence of the vitreous body, and presence of a ﬁbrous retrolenticular
membrane) in the rat (or E9.5–10.0 and E11.5–12.0, respectively, in the
mouse).It had been proposed that malformations leading to improper
closure of the optic ﬁssure also lead to escape of the vitreous
substance as well as to retinal folding (Coulombre and Coulombre,
1977). However, in the present study, all of the embryos that did not
receive supplemental ROL until E13.5 had retinal coloboma, yet the
retina when examined at E18.5 was not folded. It is possible that the
close apposition of the ﬁssure margins despite a lack of complete
closure was sufﬁcient to maintain the vitreous substance in the late
VAD eye enabling growth and preventing retinal folding. The present
ﬁndings indicate that the coloboma and folding of the retina
associated with late VAD are caused by the disruption of two distinct
developmental events.
Failure of the optic ﬁssure to close (coloboma of the retina and/or
optic nerve) has also been reported when the vitamin A signaling
pathway is altered by deletion of RARs including RARαγ and RARβ2γ
(Lohnes et al., 1994) and in a Raldh 1/3 double null mutant (Matt et al.,
2005), indicating that atRA is most probably the form of the vitamin
that is needed for this process. Lohnes et al. (1994) suggested several
possible causes of coloboma in RAR-null fetuses, including overgrowth
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retinal cells in the optic ﬁssure juncture, and maintenance of the
basement membrane in the ﬁssure margins. However, no further
experiments were done to distinguish between these possible
mechanisms. In the present work, we ﬁnd no evidence of precocious
differentiation occurring at the ﬁssure juncture in the late VAD retina,
and in fact, the differentiation of the ventral retina in late VAD
embryos at E14.5 appears to lag behind that of the VAS group. Rather,
our work provides evidence that a defect in dissolution of the
basement membrane occurs in VAD. Basement membranes are made
up of the basal and reticular lamina, and the basal lamina at the ﬁssure
margin is composed of a variety of adhesive extracellular matrix
glycoproteins, including laminin (Mosher et al., 1992; Gumbiner,
1996). The closure of the optic ﬁssure is dependent upon contact-
mediated dissolution of basement membrane in the ﬁssure margin,
and begins at E13 in the rat. Using the late VAD model system, we are
able to pinpoint the requirement for vitamin A to exactly the time that
dissolution should occur, as the addition of ROL at E12.5 prevents the
appearance of coloboma in the majority of embryos (Fig. 1D, 83%),
whereas addition at E13.5 is too late. Our results clearly show there is
persistence of the basal lamina at the ﬁssure margin in late VAD
embryos, and this likely contributes to the failure of the optic ﬁssure to
close (compare Figs. 2B and D to A and C).
A number of genes have been positively identiﬁed as playing a role
in optic ﬁssure closure, including Pitx2. Closure of the optic ﬁssure has
been shown to be defective or signiﬁcantly delayed in Pitx2 null
embryos (Gage et al., 1999). Our results point to vitamin A regulation
of Pitx2 as an event that may also be important in supporting optic
ﬁssure closure. Whereas Pitx2 mRNA was expressed throughout the
POM in VAS embryos, the expression of this mRNA was nearly
undetectable in the late VAD group (Fig. 3). Pitx2 expression could be
restored in the majority of embryos with the addition of ROL at E12.5,
which coincides with the timewhen the addition of vitamin A can also
prevent coloboma in the late VAD group, whereas addition of ROL at
E13.5 was ineffective both in restoring Pitx2 expression and in
preventing coloboma. There is evidence from cell culture experiments
that Pitx2 expression is regulated by retinoid. Lindberg et al. (1998)
ﬁrst showed Pitx2 is upregulated in embryonic stem cells by RA.
Wasiak and Lohnes (1999) showed Pitx2 upregulation by RA as early
as 12 h after RA addition in F9 embryonal carcinoma cells. More
recently, Matt et al. (2005) reported that genetic deletion of two RA
synthesizing enzymes, Raldh 1 and 3, led to a downregulation of gene
expression of Pitx2 in the POM. The ability of retinoid to signal within
the POM is supported by the presence of high levels of RARβ and RARγ
in this tissue (Grondona et al., 1996). Our results suggest that vitamin
A-dependent regulation of Pitx2 expression within the POM may
contribute to the generation of signals that are transmitted to the
ventral retina, ultimately leading to dissolution of the basement
membrane and closure of the optic ﬁssure.
Vitamin A is required for cellular proliferation and cell adhesion in the
developing retina
In late VAD embryos, the number of cyclin D1 positive cells, as well
as the expression of β-catenin and N-cadherin proteins in the retina is
altered. Cyclin D proteins regulate the progression from G1 phase to S
phase through phosphorylation and dephosphorylation of other cell
cycle-related proteins (Donovan and Dyer, 2005; Sanchez and
Dynlacht, 2005; Sherr, 1995). Of the three D-cyclins, cyclin D1 is the
most highly expressed in the retina, and is the one that is critical for
retinal development (Fantl et al., 1995; Sicinski et al., 1995; Geng et al.,
1999; Kozar et al., 2004). Retinal thinning but not folding was
observed at E18.5 if the ﬁrst dose of ROL was added on E12.5 or E13.5
in late VAD embryos (groups IV and V; Table 1; Figs. 4E and F), and this
coincided with a reduction in the number of cyclin D1 positive cells
(Fig. 7). Thinning of the retina has been reported in cyclin D1 nullfetuses, in which retina cell numbers are reduced due to a defect in
proliferation (Sicinski et al., 1995). In development, the proliferation of
RPCs is tightly controlled to ensure the developing retina develops to
the correct size. The reduced expression the marker of cell prolifera-
tion, Ki67, in addition to cyclin D1, supports the proposal that a
reduction in RPC proliferation may contribute to retinal thinning
associated in the late VAD retina.
The ﬁnding of large cell-free regions between the proliferating and
differentiating layers of the retina in rat embryos made vitamin A
deﬁcient between E10.5 and 14.5, is similar to a defect observed in
RARβ/γ compound mutants (Ghyselinck et al., 1997). These authors
found that 3 out of 5 RARβ/γ mutants examined at E14.5 had large
extracellular pockets of empty space located between the neuroblasts
at the interface of the outer and inner neuroblastic cell layers.
Interestingly, our work shows that that the atRA ligand is required to
maintain the expression of cell adhesion proteins, and we suggest that
their absence in deﬁciency may participate in the appearance of cell
free regions in the retina.
β-Catenin is a multifunctional protein that plays a role in cell
proliferation as well as in maintaining normal cell adhesion during
retinal development by its interaction with N-cadherin. β-Catenin is
one of the junction molecules that bridges N-cadherin, a homophilic
adhesion receptor, to the actin cytoskeleton to form the N-
cadherin–β-catenin protein complex (Gumbiner, 1996, 2005). It has
been shown that N-cadherin is important for retinal compaction and
integrity as treatment of retinal cultures from chick embryos with N-
cadherin antibody leads to the dissociation of retinal tissue or
uncompacted morphology (Matsunaga et al., 1988). In the mouse, loss
of β-catenin expression leads to disruption of cell adhesion in the
developing retina (Fu et al., 2006) that is similar in morphology to
that seen in rat embryos that are VAD from E10.5 to E14.5. There are
large cell-free regions, and there is a progressive loss of the radial
orientation of cells, and the cells appear to “round-up”. Although
cyclin D1 has been shown to be a β-catenin target gene, no signiﬁcant
changes in cell proliferation were observed in the β-catenin-deleted
murine retina at E14.5, leading Fu et al. (2006) to conclude that this
gene is essential during retinal neurogenesis as a regulator of cell
adhesion, but not as an effector of the canonical Wnt signaling
pathway. In VAD embryos, there is a signiﬁcant reduction in the
percent of cyclin D1-positive cells at a time when the expression of β-
catenin in the retina does not appear to differ from that of the VAS
group, suggesting that β-catenin may not be involved in the VAD-
dependent reduction in cyclin D1 in the retina of rat embryos, at least
at this stage of development. Our work does show that N-cadherin
and β-catenin protein levels normally increase at E14.5 and there-
after, but this does not occur in late VAD rat embryos (Fig. 9). Notably,
delaying supplementation of ROL to E14.5 eliminates the ability of the
vitamin to rescue N-cadherin and β-catenin expression, and at E16.5,
cells appear abnormal along the apical/basal axis. Thus, the loss of
these cell adhesion proteins may adversely affect the ability of both
the oval-shaped RPCs after cell division, and RGCs when they begin to
differentiate, to grow cell processes that keep the cells oriented along
the apical/basal axis (Hinds and Hinds, 1974); these events may, along
with an already thin retina, ultimately lead to folding and collapse of
the tissue.
It is not known how atRA regulates N-cadherin and β-catenin
protein levels in the retina. Work in cultured F9 and P19 cells supports
a role for the vitamin in regulating the expression of both of these
proteins. In F9 cells, atRA was shown to rapidly (within 4 h) stabilize
β-catenin at the post-translational level (Liu et al., 2002). N-cadherin
mRNA and protein are both increased within one day after treatment
of P19 cells with atRA, but whether this is a direct transcriptional
effect was not studied (Gao et al., 2001). It has recently been proposed
that RA generated by the retina diffuses to the perioptic mesenchyme
where it regulates events, such as Pitx2 expression, that feedback and
inﬂuence development of the eye in a paracrine mechanism (Matt et
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expressed in the retina (Li et al., 2000), and in the chick, Cyp1B1 is also
present (Chambers et al., 2007). It has been reported in themouse that
RARα but not RAR β and γ are expressed in the prenatal retina
(Ghyselinck et al., 1997). How atRA regulates the levels of N-cadherin
and β-catenin proteins in the retina of the rat embryo, and whether a
paracrine mechanism is operational, remains to be established.
In summary, a nutritional model of late embryonic vitamin A
deﬁciency in which vitamin A signaling is rescued by ROL addition at
varying times after E10.5 in the rat shows that the temporal
requirement for the vitamin varies for different eye structures, and
that the development of coloboma and retinal folding/collapse
represent distinct vitamin A deﬁciency-dependent defects. Vitamin
A is required for the normal expression of Pitx2 in the POM prior to
optic ﬁssure closure, and for the dissolution of the basement
membrane at the ﬁssure margin. In addition, vitamin A is also needed
to support cell proliferation within the retina, and to support the
expression of the cell adhesion receptor, N-cadherin, and the junction
protein, β-catenin. Thus, this work deﬁnes new roles for vitamin A in
cellular proliferation and in the regulation of the cell adhesion
proteins in the developing retina.
Note added in proof
Matt et al. (Dev. Biol. 320 (2008) 140–148) show Rara/b/gNCC
–/–
triple mutants exhibit severe ocular defects and conclude from Rara
null mutants that RA signaling has no autonomous function during
murine retinal lamination.
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